DEA: Clarify Your Stance on Harm Reduction Legal ambiguity is preventing doctors from best serving patients May 15, 2023
FDA Panelists Slam Agency's Proposed Opioid Trial Design Advisors said outcomes from an enriched enrollment study would not be broadly generalizable Apr 20, 2023
FDA Mulling Trial Design Issues for Long-Term Opioids in Chronic Pain Agency advisors will consider pros, cons of an enriched enrollment randomized withdrawal design Apr 17, 2023
We're Treating Low Back Pain All Wrong Let's reexamine the current approach to treatment Apr 14, 2023
All Opioid Pain Meds to Get New Safety Warnings, FDA Says Updated labeling to include warning about opioid-induced hyperalgesia Apr 13, 2023
Chronic Pain Affects 21% of Americans, CDC Reports Nearly 7% have pain severe enough to restrict daily activities Apr 13, 2023
Training Program Leads to More Buprenorphine Use in ED Intensive healthcare education also tied to better OUD treatment engagement Apr 05, 2023
New DEA License Requirement Starts in June The X waiver is gone, but clinicians may need new training to renew their DEA license Apr 05, 2023
U.S. 'Flying Blind' When It Comes to Data on Substance Use in Pregnancy Limited data "makes people think that the problem doesn't exist" Mar 31, 2023
Mothers Face Broken Addiction Treatment System Lack of comprehensive care puts pregnant, postpartum people with substance use disorder at risk Mar 31, 2023
Children Do Well With Fewer Opiates After Surgery Hospital outcomes similar when reserving opiates for breakthrough pain Mar 27, 2023
Use of EMR Directive Tied to Reduced Opioid Prescribing After Spine Surgery Small study shows drop in average number of pills at discharge Mar 27, 2023
FDA Mandate on Acetaminophen-Opioid Combinations Appeared Effective Hospitalizations for liver toxicity declined after FDA limited acetaminophen dose Mar 07, 2023
Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
Over-the-Counter Naloxone Has the Power to Save Lives But removing barriers to access is an essential next step Feb 23, 2023
What Clinicians Need to Know About Loperamide Misuse While cases have declined, use of loperamide as an opioid substitute still poses serious risks Feb 22, 2023
Proposed User Instructions for OTC Narcan Has FDA Concerned In emergency setting, proper use and administration by consumer is "essential," says agency staff Feb 14, 2023
Buprenorphine for Chronic Pain, Not Full Agonist Opioids, New VA Guidance Says Unintended consequences of the recommendation need to be evaluated, experts maintain Feb 13, 2023
Cannabis May Interfere With Pregnancy Retrospective study finds exposure linked with higher rates of stillbirth, hypertensive disorders Feb 10, 2023
Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades' Healthcare featured prominently in president's State of the Union address Feb 08, 2023
Republican Lawmakers Worry X-Waiver Elimination Could Stir Buprenorphine Diversion House members also look for ways to stop drug trafficking on Snapchat Feb 02, 2023
What Doctors Should Know About Xylazine in Fentanyl Naloxone still works but additional support may be needed; wound care a challenge Feb 01, 2023
When Surgeons Clamp Down on Opioids After Cardiac Operations Pain control feasible even when dropping to zero opioids Jan 22, 2023
Fewer Emergency Department Visits End With Opioid Prescriptions 8% of ED patients have an opioid prescribed at discharge Jan 20, 2023
More Evidence to Support Restrictive Opioid Prescribing After Cancer Surgery Significant decreases in prescription days, doses, refill requests, with few patient complaints Jan 06, 2023
White House Drug Control Office Focused on Improving Treatment Access Disrupting the illegal drug supply chain also high on the list, says ONDCP director Rahul Gupta Jan 05, 2023
The X Waiver Is Officially Dead But now, doctors will have to take substance use disorder training to get their DEA license Jan 05, 2023
Fatal Drug Overdoses Rose Among Black Women On average, overdose deaths resulted in more than three decades of life lost Dec 14, 2022
Physical and Occupational Therapy Are on the Medicare Chopping Block Cuts could be devastating to patient care if Congress doesn't take action Dec 12, 2022
Drug-Diversion Program Cut Controlled-Substance Discrepancies at Mount Sinai A daily audit of EHR and dispensing machines revealed documentation mistakes, other errors Dec 07, 2022
To Combat Opioid Epidemic, Step Up Safe Prescribing Practices, Expert Urges Overprescribing a continuing problem, Benjamin Davies tells urologists Dec 02, 2022
Spinal Cord Stimulators for Chronic Pain May Not Live Up to the Hype Retrospective study finds no reduction in opioid use vs conventional medical management Nov 28, 2022
Young Adults With Sleep Issues Face Higher Overdose Risk With Benzodiazepines Risk heightened for people with a recent prescription opioid-fill Nov 22, 2022
Gabapentin, Opioid Prescriptions More Likely to Overlap in Recent Years An unintentional consequence of opioid prescribing restrictions? Nov 21, 2022
CDC's Updated Opioid Guidelines Are Necessary, but Not Sufficient Additional steps are needed to calibrate opioid access and undo harm Nov 18, 2022
Chronic Pain: Opioids No Longer Treatment of Choice Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
CDC Just Changed Its Opioid Prescribing Guidelines. Here's What to Know. Guidance covers acute, subacute, and chronic pain and replaces 2016 guidelines Nov 03, 2022
'Pill Mill' Docs, You May Be in for a Big Scare Two recent Supreme Court cases have major implications for physician practice Oct 27, 2022
For Chronic Pain Patients, Consider Green-Tinted Glasses? Mixed results with green light therapy for fibromyalgia Oct 24, 2022
Thumbs Down for Genetic Test for Opioid Use Disorder, FDA Advisors Say False positives, false negatives remain a concern Oct 21, 2022
